Last June the annual member meeting of IMP took place in Cologne. Coinciding with the Euromit2017 conference this was a fantastic opportunity to combine both.
For years Euromit has been a place to meet for researchers, clinicians, care professionals and patient representatives, all involved in mitochondrial disease. The medical programme was attended by dozens of young researchers who wish to specialize in mitochondrial disease. This makes us very hopeful for the future. As such the entire conference breathed optimism and positive energy.
During the IMP annual member meeting a new board had to be elected. All five sitting board members were re-elected for another period of 3 years and the board was reinforced with a sixth member: Philip E. Yeske, Ph.D, Science & Alliance Officer of the United Mitochondrial Disease Foundation (USA).
Additionally, the Scientific Committee of IMP which reviews applications from researchers for endorsement/support by IMP, was reinforced with a fourth member: Alison Maguire, BSc FCA, Head of Research of the Lily Foundation (UK).
Next year's annual member meeting will take place in Cambridge, UK, directly after the Mitochondrial Medicine Conference in May.
